International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8229392
Original Article
Comparison of Intraocular Pressure Changes among Pre-Menopausal and Post-Menopausal Women
 ,
 ,
 ,
Published
Aug. 7, 2023
Abstract

Background: Glaucoma is the second leading cause of untreatable blindness. Due to decreased hormonal levels in post-menopausal women as compared to the pre-menopausal state, there is a high risk of glaucoma in post-menopausal women. Also, women with high BMI and BP have higher chances of raised IOP.

Aim: The study aims to compare intraocular pressure changes among pre-menopausal and post-menopausal women.

Material and Methods: This was a cross-sectional study conducted for a period of 3 months from April to June 2023 on 140 women of age group 40-55 years who were divided into 2 groups each having 70 women: pre-menopausal and post-menopausal. The study was started after getting clearance from the institutional ethics committee. Women underwent thorough examinations which includes BMI, BP, and IOP. All values were taken and compared using STATA and SPSS software.

Findings: The mean IOP in the pre-menopausal group was 11.75 mm of Hg and in the post-menopausal group was 13.42 mm of Hg which shows that in post-menopausal women the IOP is on the higher side and there are more chances of glaucoma in these women. The study has a p-value of 0.001.

Conclusion: The study concludes that IOP in post-menopausal is on the higher side in comparison to pre-menopausal women. It is due to the reduced estrogen levels as compared to the pre-menopausal state. It was also seen that the women in both groups who have raised BP and BMI have increased IOP in comparison to women with normal BP and BMI.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
740 Views
296 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved